Cell Culture-The mouse macrophage cell line RAW264.7 was obtained from ATCC and maintained in DMEM supplemented with 10% bovine growth serum. RAW264.7 cells were grown on 48 well or 96 well plates (seeded at 2.5x10 5 Transphosphatidylation reaction-POPG analogs were synthesized by transphosphatidylation reactions, which enable the substitution of the choline headgroup of PC with compounds containing primary alcohols (19, 20) . Aliquots of 10 -20 mg of POPC in chloroform were dried under nitrogen gas and diethyl ether was added, and the solvent was again evaporated to remove traces of chloroform. The dried POPC was suspended in 3.1 ml of diethyl ether. The desired primary alcohols were dissolved in 500 l of sodium acetate buffer (pH 5.5) containing 120 mM depending upon the reaction rates with the different primary alcohols. The summary of conditions and yield after purification by high performance liquid chromatography is listed in Table 1 . The reactions were stopped by addition of 50 l of 0.5M EDTA, and the ether was evaporated at room temperature under a stream of nitrogen gas. The residual aqueous phase was mixed with 4 ml of chloroform, 4 ml of methanol, 3 ml of 0.2M KCl, and the lipid was extracted (21) . The extracted lipids were dried using a Nitrogen gas evaporator and dissolved in chloroform: methanol (9:1).
Molecular masses of all compounds were confirmed by mass spectrometry.
High performance liquid chromatography -The POPG analogs were subjected to normal phase HPLC on a 150mm X 30 mm silica column. The HPLC purification consisted of a stationary phase solvent (A) containing hexane: isopropanol (3:4); and a mobile phase solvent (B)
containing hexane: isopropanol: aqueous 1mM ammonium acetate, 3:4:0.7). The starting solvent consisted of 55% A and 45% B. For the first 20 min of chromatography the %B was increased to 60%. From 20-22 min the %B increased to 100%. From 22-42 min the solvent was 100%B.
The HPLC effluent was monitored at 200 nm using a photodiode array detector. The major transphosphatidylation product peak was collected from the HPLC, and dried using a nitrogen gas evaporator, and the lipid residue was extracted by Bligh and Dyer method. at a flow rate of 5 l/min. In the negative ion mode, the experimental parameters used to obtain the enhanced mass spectra (EMS) were an electrospray voltage of -4500 V and a declustering potential of -45 V. EMS were obtained using the terminal triple quadrupole as an ion trap and were used to confirm the m/z of the POPG analogs of interest. Additionally, structural characterization was carried out using tandem mass spectrometry in the negative ion mode with a collision energy of -40 V and nitrogen as the collision gas. For these studies, the terminal quadrupole was used as an ion trap in order to obtain enhanced product ion (EPI) spectra of the POPG analogs. The EPI spectra gave two dominant product ions at m/z 255.1 (palmitic acid) and 281.1 (oleic acid) for all of the POPG analogs in this study.
Thin layer chromatography-
Western Blot Analysis-RAW264.7 cells were plated at a density of 2.5 x10 5 cells/well in a 48 well plate for 24 hrs prior to stimulation. After stimulation, macrophages were washed twice with icecold PBS and lysed with 1x SDS sample buffer containing Sigma protease inhibitor cocktail.
Lysates were boiled for 5 min, and then proteins were resolved on 8-16% gradient Tris-SDSpolyacrylamide gels. The separated proteins were transferred to nitrocellulose membranes and subsequently incubated in blocking buffer containing 20 mM Tris-HCl buffer, pH 7.6, 137 mM NaCl, 0.1% Tween 20 and 5% nonfat milk) (TBS), and then incubated in the same solution overnight at 4 °C with primary antibody. The membranes were washed with TBS containing 0.1% TLR ligands (LPS-10ng/ml or MALP-2-0.2ng/ml) in the same medium. The culture medium was removed after 90 min of stimulation, centrifuged, and the amount of radioactivity in the supernatant was measured by scintillation counting. The cell monolayer was solubilized with 0.1%
Triton X-100. The amount of radioactivity released into the culture medium was expressed as percent of the total radioactivity incorporated in the cells (23) .
Binding of CD14 and MD-2 to Phospholipids-Phospholipids (0.625 nmol) in 20 l aliquots of ethanol were pipetted onto 96-well half-area plates (Corning Inc., Corning, NY), and the solvent was evaporated using a warm air blower. The recovery of POPG and analogs was ~50% of the molar quantity applied to each well, with no major differences among all the phospholipids except for two. Two lipids that failed to bind CD14 and MD-2, phosphatidylcholine and phosphatidyl-2'-aminopropanediol were recovered at ~80% of the quantity applied to each well.
Competitive binding of Kdo2-Lipid A to CD14 or MD-2 in the presence of lipid-Kdo2-Lipid A (2.8 g) in 20 l aliquots of ethanol was pipetted onto a 96-well half-area plate, and the solvent was evaporated using a warm air blower. After the nonspecific binding was blocked with buffer A, mixtures of human CD14 (4g/ml) or MD-2 (1g/ml) and phospholipid liposomes (100g/ml or 50g/ml) in buffer A, which were pre-incubated at 37 °C for 30 min, were added and further incubated at 37 °C for 1 h. The amount of bound human CD14 or MD-2 was detected using the method described above. The quantification of secreted TNF- was performed using a human TNF- ELISA kit from Thermo Fisher Scientific.
Analysis of TNF
Statistical analysis-All results are expressed as mean  S.E. Data were analyzed using analysis of variance. The p value for significance was set at 0.05.
Results:
Synthesis of POPG analogs-Transphosphatidylation reactions were performed with POPC as the starting substrate, cabbage phospholipase D as the catalyst, and 11 individual primary alcohols as acceptors for phosphatidate transfer (19, 20) . From these reactions we produced 11
analogs of POPG in yields of 18.5-60.1% (Table 1 ). The structure of POPG is shown in Figure   1A and the various headgroups are shown in Figure 1B . Figure 1C (Table 1) .
Hydroxyl group substitution of phospholipid headgroup aliphatic chains is an important determinant of TLR4 antagonism-In previous work we demonstrated that POPG inhibited TLR4 signaling in RAW264.7 macrophages (13, 14) . In Fig. 2 we examined 10ng/ml LPS- value of 4 ± 1.4 g/ml. Analogs with short aliphatic headgroups were comparable to POPG with IC50s of 3.6 ± 1.2 g/ml for the methyl substitution and 4.1 ± 1.6 g/ml for the ethyl substitution.
In contrast, the longer chain aliphatic headgroups were significantly less effective with IC50s of 18.6 ± 2.6 g/ml for the propyl headgroup and 25.6 ± 4.1 g/ml for the butyl headgroup headgroup is significantly weaker. In addition, POPA, which is anionic but contains no aliphatic headgroup, is ineffective as an antagonist of p38 phosphorylation.
In Fig. 5B the effects of addition of hydroxyl groups to the propyl and butyl aliphatic chains was also quantified. The addition of hydroxyl moieties to the 3' and 4' carbons of the butyl aliphatic chain markedly improved the antagonism of p38 phosphorylation, when compared with the unsubstituted butyl headgroup. The addition of hydroxyl groups to the 2' and 3' carbons of the propyl aliphatic chain did not change the inhibition of p38 phosphorylation when compared to the unsubstituted propyl headgroup.
The antagonistic effects of branched chain analogs were also examined in Fig. 5A and 5B. The addition of an amine to the 2' carbon of the (3'-hydroxy)-propyl headgroup almost completely eliminated the antagonism of LPS-dependent p38 phosphorylation. In contrast, the addition of 1 or 2 methyl groups to the 2' carbon of the (3'-hydroxy)-propyl headgroup yielded similar levels of antagonism of p38 phosphorylation that were not markedly different from the unmodified propyl group.
NFkB activation is also suppressed by POPG analogs-NFkB is the major transcription factor driving LPS induced inflammatory gene expression, including TNF. In experiments described in 10A,E). Addition of hydroxyl groups to the propyl and butyl aliphatic headgroup chains modestly shifted the IC50 values much closer to that of POPG (Fig. 10B,E) . The presence of a single methyl branch on the 2' carbon along with the 3' hydroxyl of the propyl backbone did not alter the IC50 compared to POPG; but the addition of a second methyl branch yielded an IC50 >200g/ml (Fig. 10C ). As shown in Fig. 10D , the control phospholipid, POPC, and the analog harboring the 2'amino-propanediol headgroup, failed to inhibit TLR2/6 activation. Thus, the studies analyzing antagonism of TLR2/6 by POPG analogs, demonstrate IC50 values nearly 10-fold higher than values obtained for TLR4 antagonism, and differ in specificity for variation in headgroup structure (e.g. compare the antagonism of TLR2 and TLR4 by analogs with methyl or ethyl headgroups). These data demonstrate that manipulation of both the concentration and structure of POPG analogs can be used to selectively antagonize specific TLRs.
To test whether CD14 interactions with phospholipids played a role in antagonism of MALP-2 signaling, we examined interactions between the agonist, the protein and POPG. CD14 failed to show any direct binding interaction to solid phase MALP-2. Similarly, MALP-2 showed only very marginal inhibition of CD14 recognition of solid phase POPG. These data lead us to conclude that POPG antagonism of TLR2 activation does not require CD14.
Discussion:
Pulmonary surfactant plays an essential role in mammalian respiratory physiology and also contributes significantly to innate immune functions of the lung (1, 3, 10). The pulmonary surfactant complex contains extraordinarily high levels of the PG phospholipid class, with the POPG molecular species being the most abundant in humans (32). Both in vitro and in vivo studies demonstrate important innate immune functions for POPG (10) (11) (12) (13) (14) (15) (16) 33 ). The lipid acts as a potent antagonist of TLRs 1,2,4 and 6, and suppresses the pro-inflammatory signaling through these receptors (13, 14) . The antagonism of TLR4 activation occurs by binding of POPG to the LPS binding sites of the accessory molecules CD14 and MD-2 (13).
In an effort to query the specificity of the POPG antagonism of TLRs, we synthesized a small library of analogs that differ in polar headgroup structure, since previous work demonstrated that this portion of the molecule was critical for function (13, 14) . Transphosphatidylation reactions Recent studies also demonstrate that exogenously supplied POPG turns over relatively rapidly in mouse lung (16, 17) . It is currently unknown if these analogs will turn over at different rates within the lung, but structural variants with longer turnover times might have improved biological efficacy for suppressing deleterious TLR4 activation that can occur in acute lung injury and acute respiratory distress syndrome (35-37). Abbreviations for lipids are the same as in Figure 1 .
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